- 全部删除
您的购物车当前为空
NZ-97 是一种二肽基肽酶 4 (DPP4) 的抑制剂,其 IC50 为 18 nM。NZ-97 的初始血浆暴露度较低,Cmax 达到 0.13 µM,并在 8 小时内被清除。NZ-97 能改善小鼠模型中由 Lipopolysaccharides 诱导的肺损伤和 Bleomycin 诱导的肺纤维化。
NZ-97 是一种二肽基肽酶 4 (DPP4) 的抑制剂,其 IC50 为 18 nM。NZ-97 的初始血浆暴露度较低,Cmax 达到 0.13 µM,并在 8 小时内被清除。NZ-97 能改善小鼠模型中由 Lipopolysaccharides 诱导的肺损伤和 Bleomycin 诱导的肺纤维化。

NZ-97 相关产品
| 产品描述 | NZ-97 is an inhibitor of dipeptidyl peptidase 4 (DPP4) with an IC50 of 18 nM. It exhibits low initial plasma exposure with a Cmax of 0.13 µM and is eliminated within 8 hours. NZ-97 can ameliorate lipopolysaccharides-induced lung injury and bleomycin-induced pulmonary fibrosis in mouse models. |
| 靶点活性 | DPP8:1258 nM, DPP9:561 nM, DPP4:18 nM |
| 分子式 | C43H67N5O9 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容